Reports for TARO-DOXORUBICIN LIPOSOMAL
Brand name
TARO-DOXORUBICIN LIPOSOMAL
Company Name
TARO PHARMACEUTICALS INC
|
Drug Identification Number
02493020 |
Ingredients
DOXORUBICIN HYDROCHLORIDE |
Ingredient Strength
2 MG |
ATC Code
L01DB |
ATC Descriptor
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TARO-DOXORUBICIN LIPOSOMAL | 10mL Vial | Resolved | 2024-09-12 | 2024-10-31 | 237366 |
| TARO-DOXORUBICIN LIPOSOMAL | 10ML | Resolved | 2022-11-04 | 2023-01-19 | 173730 |
Showing 1 to 2 of 2
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0